BIOMARKER:

RET M918T

Entrez ID:

Related biomarkers:

‹

›

RET M918T RET M918T	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	cabozantinib capsule Sensitive: A2 - Guideline
RET M918T RET M918T	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	pralsetinib Sensitive: C3 – Early Trials
RET M918T RET M918T	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	sorafenib Sensitive: C3 – Early Trials
RET M918T RET M918T	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	selpercatinib Sensitive: C3 – Early Trials
RET M918T RET M918T	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	everolimus + vandetanib Sensitive: C4 – Case Studies
RET M918T RET M918T	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	everolimus Sensitive: C4 – Case Studies
RET M918T RET M918T	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	vandetanib Sensitive: C4 – Case Studies
RET M918T RET M918T	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	sunitinib Sensitive: C4 – Case Studies
RET M918T RET M918T	Thyroid Gland Carcinoma Thyroid Gland Carcinoma	XMD15-44 Sensitive: D – Preclinical
RET M918T RET M918T	Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma	AMG 706 Resistant: D – Preclinical
RET M918T RET M918T	Thyroid Gland Carcinoma Thyroid Gland Carcinoma	HG-6-63-01 Sensitive: D – Preclinical
RET M918T RET M918T	Thyroid Gland Papillary Carcinoma Thyroid Gland Papillary Carcinoma	AZD1480 Sensitive: D – Preclinical
RET M918T RET M918T	Thyroid Gland Carcinoma Thyroid Gland Carcinoma	ALW-II-41-27 Sensitive: D – Preclinical